Target enrollment milestone reached in the Phase 3 EMERALD study
Life cycle planning advancing in parallel with current Phase 3 monotherapy program
PR Newswire
WALTHAM, Mass. and FLORENCE, Italy, Sept. 25, 2020
PR Newswire
WALTHAM, Mass. and FLORENCE, Italy, Sept. 25, 2020
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey